Different doses of methimazole treatment of children and adolescents with graves’ disease: a clinical study based on 161 cases of outpatients
Abstract Objective This study aimed to evaluate the association between the initial dose of MMI and the clinical course, as well as adverse effects on young people with GD. Methods One hundred and sixty-one children and adolescents with newly diagnosed GD were enrolled for this study and categorized...
Main Authors: | Peng Li, Wei Wang, Meiqin Yan, Xianhui Zhang, Jie Pan, Lina Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-023-01484-2 |
Similar Items
-
Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
by: Hyun Gyung Lee, et al.
Published: (2021-09-01) -
Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves' disease
by: Sun Hee Lee, et al.
Published: (2013-03-01) -
Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013
by: Sun Mi Hwang, et al.
Published: (2016-06-01) -
Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
by: Fereidoun Azizi, et al.
Published: (2021-04-01) -
Evaluating the Role of Circulating Dendritic Cells in Methimazole-Treated Pediatric Graves’ Disease Patients
by: Aleksandra Starosz, et al.
Published: (2021-01-01)